Back to Search
Start Over
Potential benefits of anticoagulant doses of low molecular weight heparin in COVID-19: An observational retrospective study
- Source :
- Emergency Care Journal, Vol 17, Iss 3 (2021)
- Publication Year :
- 2021
- Publisher :
- PAGEPress Publications, 2021.
-
Abstract
- Hypercoagulability is a common complication of the systemic inflammation related to coronavirus disease 2019 creating debate within the critical care community on the therapeutic utility of Low Molecular Weight Heparin (LMWH). We collected data on consecutive patients with COVID-19 admitted to the Emergency Department of Castel San Giovanni Hospital, between February 29th and April 7th, 2020. Exclusion criteria were age
- Subjects :
- Mechanical ventilation
Medicine (General)
medicine.medical_specialty
business.industry
medicine.drug_class
medicine.medical_treatment
Anticoagulant
COVID-19
Low molecular weight heparin
Retrospective cohort study
Pneumonia
Emergency department
heparin
mortality
R5-920
Internal medicine
Medicine
business
Complication
Survival rate
thrombosis
Dialysis
Subjects
Details
- ISSN :
- 22822054 and 18269826
- Volume :
- 17
- Database :
- OpenAIRE
- Journal :
- Emergency Care Journal
- Accession number :
- edsair.doi.dedup.....cb5e6eb5900e860f644ce1904d2e466f
- Full Text :
- https://doi.org/10.4081/ecj.2021.9795